120 related articles for article (PubMed ID: 3511099)
1. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.
Nanjo K; Sanke T; Miyano M; Okai K; Sowa R; Kondo M; Nishimura S; Iwo K; Miyamura K; Given BD
J Clin Invest; 1986 Feb; 77(2):514-9. PubMed ID: 3511099
[TBL] [Abstract][Full Text] [Related]
2. Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome.
Haneda M; Polonsky KS; Bergenstal RM; Jaspan JB; Shoelson SE; Blix PM; Chan SJ; Kwok SC; Wishner WB; Zeidler A
N Engl J Med; 1984 May; 310(20):1288-94. PubMed ID: 6371526
[TBL] [Abstract][Full Text] [Related]
3. [The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus and its related metabolic traits].
Xiang K; Fang Q; Zheng T; Jia W; Wang Y; Zhang R; Li J; Shen K
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):426-30. PubMed ID: 11774208
[TBL] [Abstract][Full Text] [Related]
4. Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas.
Sakura H; Iwamoto Y; Sakamoto Y; Kuzuya T; Hirata H
J Clin Invest; 1986 Dec; 78(6):1666-72. PubMed ID: 3537011
[TBL] [Abstract][Full Text] [Related]
5. Insulin Wakayama: familial mutant insulin syndrome in Japan.
Nanjo K; Miyano M; Kondo M; Sanke T; Nishimura S; Miyamura K; Inouye K; Given BD; Chan SJ; Polonsky KS
Diabetologia; 1987 Feb; 30(2):87-92. PubMed ID: 3552828
[TBL] [Abstract][Full Text] [Related]
6. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
[TBL] [Abstract][Full Text] [Related]
7. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes.
Boey D; Heilbronn L; Sainsbury A; Laybutt R; Kriketos A; Herzog H; Campbell LV
Neuropeptides; 2006 Oct; 40(5):317-24. PubMed ID: 17045646
[TBL] [Abstract][Full Text] [Related]
8. A 25-year follow-up study of glucose tolerance in first-degree relatives of type 2 diabetic patients: association of impaired or diabetic glucose tolerance with other components of the metabolic syndrome.
Nauck MA; Meier JJ; Wolfersdorff AV; Tillil H; Creutzfeldt W; Köbberling J
Acta Diabetol; 2003 Dec; 40(4):163-72. PubMed ID: 14740275
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
10. Insulin binding to circulating monocytes and erythrocytes in patients with non-insulin-dependent diabetes in the young.
Naidoo C; Jialal I; Dunn RD; Govender T; Joubert SM
Diabetes Res; 1987 Jan; 4(1):35-8. PubMed ID: 3552365
[TBL] [Abstract][Full Text] [Related]
11. Familial hyperinsulinemia associated with secretion of an abnormal insulin, and coexistence of insulin resistance in the propositus.
Vinik AI; Seino S; Funakoshi A; Schwartz J; Matsumoto M; Schteingart DE; Fu ZZ; Tsai ST
J Clin Endocrinol Metab; 1986 Apr; 62(4):645-52. PubMed ID: 3512591
[TBL] [Abstract][Full Text] [Related]
12. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus.
Migdalis IN; Zachariadis D; Kalogeropoulou K; Nounopoulos C; Bouloukos A; Samartzis M
Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025
[TBL] [Abstract][Full Text] [Related]
13. [Insulin receptor Arg1131-->Gln: a novel mutation in the catalytic loop of insulin receptor observed in insulin resistant diabetes].
Kasuga M; Kishimoto M; Hashiramoto M; Yonezawa K; Kazumi T; Hagino H; Shii K
Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):968-71. PubMed ID: 1470163
[TBL] [Abstract][Full Text] [Related]
14. Mutant insulin syndrome: identification of two families with [LeuA3]insulin and determination of its biological activity.
Nanjo K; Sanke T; Kondo M; Nishimura S; Miyano M; Linuma J; Miyamura K; Inouye K; Given BD; Polonsky KS
Trans Assoc Am Physicians; 1986; 99():132-42. PubMed ID: 3299984
[No Abstract] [Full Text] [Related]
15. Insulin resistance and diabetes due to a genetic defect in insulin receptors.
Scarlett JA; Kolterman OG; Moore P; Saekow M; Insel J; Griffin J; Mako M; Rubenstein AH; Olefsky JM
J Clin Endocrinol Metab; 1982 Jul; 55(1):123-31. PubMed ID: 7042734
[TBL] [Abstract][Full Text] [Related]
16. [Review for clinical molecular genetics of mutant insulin].
Sanke T; Nanjo K
Nihon Rinsho; 1994 Oct; 52(10):2550-5. PubMed ID: 7983776
[TBL] [Abstract][Full Text] [Related]
17. Diabetes due to secretion of an abnormal insulin.
Given BD; Mako ME; Tager HS; Baldwin D; Markese J; Rubenstein AH; Olefsky J; Kobayashi M; Kolterman O; Poucher R
N Engl J Med; 1980 Jan; 302(3):129-35. PubMed ID: 7350438
[TBL] [Abstract][Full Text] [Related]
18. Familial hyperinsulinemia complicated by extreme insulin resistance during pregnancy: a probable postreceptor defect.
Plehwe WE; Maitland JE; Williams PF; Shearman RP; Turtle JR
J Clin Endocrinol Metab; 1985 Jul; 61(1):68-77. PubMed ID: 3889041
[TBL] [Abstract][Full Text] [Related]
19. [Recombinant DNA in the study of diabetes mellitus].
Pankov IuA
Mol Biol (Mosk); 1990; 24(5):1173-80. PubMed ID: 2290417
[TBL] [Abstract][Full Text] [Related]
20. Mutant insulin syndromes.
Vinik A; Bell G
Horm Metab Res; 1988 Jan; 20(1):1-10. PubMed ID: 3286444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
